# Effect of Vericiguat on cardiAc Remodeling in Patients With Heart faiLure and Reduced Ejection fractioN (HFrEF): A Prospective sTudy usIng NOvel Echocardiographic Imaging Techniques (VALENTINO)

> **NCT07472595** · — · COMPLETED · sponsor: **Chinese University of Hong Kong** · enrollment: 40 (actual)

## Conditions studied

- HFrEF - Heart Failure With Reduced Ejection Fraction

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07472595
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-09
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2026-03-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07472595

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07472595, "Effect of Vericiguat on cardiAc Remodeling in Patients With Heart faiLure and Reduced Ejection fractioN (HFrEF): A Prospective sTudy usIng NOvel Echocardiographic Imaging Techniques (VALENTINO)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07472595. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*